June 22, 2024

Beta Glucan Market Size to Worth USD 1,156 Million by 2033

The global beta glucan market size accounted for US$ 612 million in 2023 and is projected to reach around USD 1,156 million by 2033, growing at a CAGR of 6.56% from 2024 to 2033.

Key Points

  • Europe led the market with the biggest market share of 37% in 2023.
  • By region, Asia Pacific is expected to grow significantly during the forecast period.
  • By source, the cereal segment holds the largest market share of 34% in 2023.
  • By source, the yeast segment is expected to gain a significant share during the forecast period.
  • By application, in 2023, the food & beverages segment held the largest share of around 35.6%.
  • By application, the cosmetic & personal care segment is expected to grow significantly during the forecast period.
  • By product, the soluble segment held the largest share of around 61.5% in 2023.
  • By product, the insoluble segment is expected to expand at the fastest rate over the forecast period.

Beta Glucan Market Size 2024 to 2033

Report Summary

The global beta glucan market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the beta glucan market across the globe.

A comprehensive estimate on the beta glucan market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of beta glucan during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3916

Beta Glucan Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 6.56%
Global Market Size in 2023 USD 612 Million
Global Market Size by 2033 USD 1,156 Million
Largest Market Europe
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Source, By Application, and By Product
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized beta glucan market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Antidiabetics Market Size to Rake USD 227.50 Billion by 2033

Market Players

The report includes the profiles of key beta glucan market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Recent Developments

  • In July 2023, medicine manufacturer Dr. Reddy’s Laboratories introduced CeleHealth Kidz Immuno Plus Gummies to the Indian market, marking their entry into the infant nutrition sector. The product attempts to meet the dietary needs related to the increasing worries about kid immunity in India.
  • In July 2023, BENEO announced the launch of the company’s first barley beta-glucan ingredient, the Orafti β-Fit, for heart health and blood sugar management. This new launch is expected to improve BENEO’s global market reach in the fiber and cardio-metabolic health markets.

Beta Glucan Market Companies

  • Biotec Pharmacon ASA.
  • Biothera Pharmaceticals.
  • Ceapro Inc.
  • Immunomedics.
  • Super Beta Glucan Inc.
  • DSM NV.
  • Tate & Lyle plc (Tate & Lyle Oat Ingredients)
  • Groupe Soufflet SA (AIT Ingredients)

Segment Covered in the Report

By Source

  • Cereal
  • Mushroom
  • Yeast
  • Seaweed

By Application

  • Food & Beverages
  • Cosmetics & Personal Care
  • Pharmaceuticals
  • Animal Feed
  • Others

By Product

  • Soluble
  • Insoluble

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Beta Glucan Market 

5.1. COVID-19 Landscape: Beta Glucan Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Beta Glucan Market, By Source

8.1. Beta Glucan Market Revenue and Volume, by Source, 2024-2033

8.1.1 Cereal

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Mushroom

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Yeast

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Seaweed

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Beta Glucan Market, By Application

9.1. Beta Glucan Market Revenue and Volume, by Application, 2024-2033

9.1.1. Food & Beverages

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Cosmetics & Personal Care

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Pharmaceuticals

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Animal Feed

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Beta Glucan Market, By Product 

10.1. Beta Glucan Market Revenue and Volume, by Product, 2024-2033

10.1.1. Soluble

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Insoluble

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Beta Glucan Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by Product (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Source (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by Product (2021-2033)

Chapter 12. Company Profiles

12.1. Biotec Pharmacon ASA.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Biothera Pharmaceticals.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Ceapro Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Immunomedics.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Super Beta Glucan Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. DSM NV.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Tate & Lyle plc (Tate & Lyle Oat Ingredients)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Groupe Soufflet SA (AIT Ingredients)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com


Prathamesh

Leave a Reply

Your email address will not be published. Required fields are marked *